MedTrace Logo

Optic Nerve and Retinal Functions With Bevacizumab

NCT01361828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2011-05-27

No results posted yet for this study

Summary

The purpose of this study is to investigate the possible affection of optic nerve and retinal functions following intravitreal bevacizumab injection in human eyes.

Conditions

  • Choroidal Neovascular Membrane

Interventions

PROCEDURE

Electrophysiology

Visual Evoked Potential and Elctroretinogram

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Tamer A macky · Cairo University

Eligibility

Min Age
24 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361828 on ClinicalTrials.gov